Hereditary diffuse gastric cancers are rare, accounting for at most 1-3% of gastric cancers. It can be caused by a mutation in the tumour-suppressor gene CDH1. A healthy person carrying a CDH1 mutation has a cumulative risk of developing gastric cancer of 70-80%. In most cases, gastric cancer is detected before the age of 40 years. The effectiveness of screening for hereditary diffuse gastric cancer or early detection with twice-yearly upper GI endoscopy with blind biopsies is highly questionable. Given the poor prognosis of patients with hereditary diffuse gastric cancer, prophylactic gastrectomy can be considered an option for patients with a CDH1 mutation. It is recommended that the supervision, screening and possible preventative gastre...
Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and lobular ...
Background: Hereditary diffuse gastric cancer (HDGC) is defined by germline mutations in the E-cadhe...
IMPORTANCE E-cadherin (CDH1) is a cancer predisposition gene mutated in families meeting clinically...
Contains fulltext : 49669.pdf (publisher's version ) (Closed access)Hereditary dif...
The only known genetic causes of hereditary diffuse gastric cancer (HDGC) are germline mutations in ...
Hereditary diffuse gastric cancer (HDGC) is a relatively rare disorder, with a mutated CDH1 gene as ...
Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characteri...
25-30% of families fulfilling the criteria for hereditary diffuse gastric cancer have germline mutat...
Worldwide the gastric cancer holds fifth place above all oncological diseases and the third among th...
Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and lobular ...
With a current molecular revolution, hereditary gastric cancer represents a small group of patients ...
Abstract Background Gastric cancer is the fifth most prevalent and the third most lethal cancer worl...
Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and lobular ...
Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and lobular ...
Introduction: Gastric cancer is inherited as an autosomal dominant condition in hereditary diffuse g...
Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and lobular ...
Background: Hereditary diffuse gastric cancer (HDGC) is defined by germline mutations in the E-cadhe...
IMPORTANCE E-cadherin (CDH1) is a cancer predisposition gene mutated in families meeting clinically...
Contains fulltext : 49669.pdf (publisher's version ) (Closed access)Hereditary dif...
The only known genetic causes of hereditary diffuse gastric cancer (HDGC) are germline mutations in ...
Hereditary diffuse gastric cancer (HDGC) is a relatively rare disorder, with a mutated CDH1 gene as ...
Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characteri...
25-30% of families fulfilling the criteria for hereditary diffuse gastric cancer have germline mutat...
Worldwide the gastric cancer holds fifth place above all oncological diseases and the third among th...
Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and lobular ...
With a current molecular revolution, hereditary gastric cancer represents a small group of patients ...
Abstract Background Gastric cancer is the fifth most prevalent and the third most lethal cancer worl...
Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and lobular ...
Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and lobular ...
Introduction: Gastric cancer is inherited as an autosomal dominant condition in hereditary diffuse g...
Germline CDH1 mutations confer a high lifetime risk of developing diffuse gastric (DGC) and lobular ...
Background: Hereditary diffuse gastric cancer (HDGC) is defined by germline mutations in the E-cadhe...
IMPORTANCE E-cadherin (CDH1) is a cancer predisposition gene mutated in families meeting clinically...